Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Tangible Net Worth Ratio
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Tangible Net Worth Ratio of 96.1% as of September 2025. This metric is calculated by deducting intangible assets (CN¥77.73 Million) from net assets (CN¥2.02 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Qianjiang Yongan Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Qianjiang Yongan Pharmaceutical Co Ltd Tangible Net Worth Ratio (2006–2024)
This chart shows how Qianjiang Yongan Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 96.1%, reflecting net assets of CN¥2.02 Billion with intangible assets of CN¥77.73 Million CNY. For live market cap and overall valuation, see Qianjiang Yongan Pharmaceutical Co Ltd market capitalisation.
Annual Tangible Net Worth Ratio for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Qianjiang Yongan Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 96.1% | CN¥2.04 Billion | CN¥79.56 Million | CN¥2.31 Billion | ▲ +0.1 pp |
| 2023 | 96.0% | CN¥2.05 Billion | CN¥82.39 Million | CN¥2.35 Billion | ▼ 0.0 pp |
| 2022 | 96.0% | CN¥2.10 Billion | CN¥84.49 Million | CN¥2.42 Billion | ▲ +0.5 pp |
| 2021 | 95.5% | CN¥1.96 Billion | CN¥87.93 Million | CN¥2.29 Billion | ▲ +0.5 pp |
| 2020 | 95.0% | CN¥1.81 Billion | CN¥89.82 Million | CN¥2.16 Billion | ▲ +0.4 pp |
| 2019 | 94.7% | CN¥1.66 Billion | CN¥88.25 Million | CN¥1.91 Billion | ▲ +0.2 pp |
| 2018 | 94.5% | CN¥1.61 Billion | CN¥88.64 Million | CN¥1.93 Billion | ▲ +1.4 pp |
| 2017 | 93.1% | CN¥1.34 Billion | CN¥92.56 Million | CN¥1.58 Billion | ▼ -0.2 pp |
| 2016 | 93.3% | CN¥1.18 Billion | CN¥78.90 Million | CN¥1.27 Billion | ▲ +0.7 pp |
| 2015 | 92.6% | CN¥1.12 Billion | CN¥82.73 Million | CN¥1.20 Billion | ▼ -0.2 pp |
| 2014 | 92.9% | CN¥1.11 Billion | CN¥79.15 Million | CN¥1.19 Billion | ▲ +0.4 pp |
| 2013 | 92.4% | CN¥1.08 Billion | CN¥81.82 Million | CN¥1.20 Billion | ▼ -1.0 pp |
| 2012 | 93.4% | CN¥1.09 Billion | CN¥72.33 Million | CN¥1.21 Billion | ▲ +0.2 pp |
| 2011 | 93.2% | CN¥1.06 Billion | CN¥71.75 Million | CN¥1.16 Billion | ▼ -1.8 pp |
| 2010 | 95.0% | CN¥1.01 Billion | CN¥50.41 Million | CN¥1.09 Billion | ▲ +10.9 pp |
| 2009 | 84.1% | CN¥324.17 Million | CN¥51.50 Million | CN¥394.00 Million | ▲ +0.5 pp |
| 2008 | 83.6% | CN¥259.12 Million | CN¥42.49 Million | CN¥379.16 Million | ▲ +6.3 pp |
| 2007 | 77.4% | CN¥191.53 Million | CN¥43.38 Million | CN¥254.42 Million | ▼ -6.1 pp |
| 2006 | 83.4% | CN¥104.99 Million | CN¥17.42 Million | CN¥151.23 Million | — |